MedTrace Logo

Talent Converter Post-Approval Study

NCT01129609 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-10-29

Study results available
· View outcomes & findings →

Summary

The primary endpoint is successful secondary endovascular treatment with the Talent Converter stent graft of subjects having received prior endovascular repair of infrarenal abdominal aortic or aortoiliac aneurysms using the Talent or AneuRx Bifurcated Stent Grafts, in which there is inadequate proximal fixation, seal, overlapping of modular components or unattainable contralateral limb cannulation.

Treatment success is defined as a composite of successful vessel access, successful insertion of the delivery system, successful deployment of the Converter stent graft at the intended treatment site and absence of Type I endoleak at the 1 month follow-up visit.

Conditions

  • Abdominal Aortic Aneurysms

Interventions

DEVICE

Talent Converter Stent Graft and Talent Occluder with Occluder Delivery System

All subject enrolled will be attempted to be treated with or will be treated with the Talent Converter Stent Graft

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-06-30
Completion
2017-09-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01129609 on ClinicalTrials.gov